2001 (7) TMI 557 - AT - Central Excise

Summary

The appeal by M/s. Ranbaxy Laboratories was allowed by the Appellate Tribunal CEGAT, New Delhi. The tribunal found that the invoices contained the necessary details for Modvat credit, and the allegation of excess duty payment was not raised in the show cause notice. The impugned order disallowing Modvat credit was set aside.